September 28, 2014 | Israel Chemicals (ICL) announced the pricing of its New York Stock Exchange IPO at $7 a share. According to reports, ICL will sell over 60 million ordinary shares which are currently owned by the company’s majority shareholder, Israel Corporation, in a second offering at a price of $7 a share. In addition, the underwriters for the IPO, which include Morgan Stanley, Barclays Capital, Goldman Sachs, Deutsche Bank and BMO Capital Markets, will be given a 30-day option to purchase an additional 6 million shares. Due to Israel Corporations majority shareholder position in the company, ICL will not receive financial proceeds from the sale. ICL is a multi-national manufacturer, producer, developer and marketer of fertilizers, metals and other special purpose chemical products that was founded in 1968.
Facebook comments